Browsing College of Pharmacy by Author "El-Bardissy, Ahmed"
Now showing items 1-5 of 5
-
Assessment of the attitude, awareness and practice of periprocedural warfarin management among health care professional in Qatar. A cross sectional survey
Eljilany, Islam; El-Bardissy, Ahmed; Nemir, Arwa; Elzouki, Abdel Naser; El Madhoun, Ihab; Al-Badriyeh, Daoud; Elewa, Hazem... more authors ... less authors ( Springer , 2020 , Article)It is estimated that 10–15% of oral anticoagulant (OAC) patients, would need to hold their OAC for scheduled surgery. Especially for warfarin, this process is complex and requires multi-layer risk assessment and decisions ... -
Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic review and a meta-analysis
Elshafei, Mohamed Nabil; Mohamed, Mouhand F.H.; El-Bardissy, Ahmed; Ahmed, Mohamed Badie; Abdallah, Ibtihal; Elewa, Hazem; Danjuma, Mohammed... more authors ... less authors ( Springer , 2021 , Article)Direct oral anticoagulant (DOAC) agents are becoming the anticoagulation strategy of choice. However, their use in the treatment of acute venous thromboembolism (VTE) in morbidly obese patients (bodyweight of > 120 kg or ... -
Genetic and non-genetic factors impact on inr normalization in preprocedural warfarin management
Eljilany, Islam; Elarref, Mohamed; Shallik, Nabil; Elzouki, Abdel Naser; Bader, Loulia; El-Bardissy, Ahmed; Abdelsamad, Osama; Al-Badriyeh, Daoud; Cavallari, Larisa H.; Elewa, Hazem... more authors ... less authors ( Dove Medical Press , 2021 , Article)Background: Annually, 10% of warfarin patients will likely need to stop warfarin prior to elective surgery to achieve a baseline international normalization ratio (INR) level (INR ≤ 1.2) at the time of the procedure. This ... -
Genetic polymorphism effect on warfarin–rifampin interaction: A case report and review of literature
Salem, Muhammad; Eljilany, Islam; El-Bardissy, Ahmed; Elewa, Hazem ( Dove Medical Press , 2021 , Article)Warfarin–rifampin interaction has been reported since the 1970s. Due to rifampin’s strong induction of CYP2C9, most cases could not attain the target international normalized ratio (INR) despite warfarin dose escalation. ... -
Warfarin-Rifampin-Gene (WARIF-G) Interaction: A Retrospective, Genetic, Case–Control Study
Salem, Muhammad; El-Bardissy, Ahmed; Elshafei, Mohamed Nabil; Khalil, Ahmed; Mahmoud, Hesham; Fahmi, Amr Mohamed; Kasem, Mohamed; Bader, Loulia; Sherbash, Mohamed; Elawady, Mostafa Ibrahim; Abdalazim, Walaa; Howady, Faraj; Elewa, Hazem... more authors ... less authors ( Wiley-Blackwell , 2023 , Article)Warfarin is extensively metabolized by cytochrome P450 2C9 (CYP2C9). Concomitant use with the potent CYP2C9 inducer, rifampin, requires close monitoring and dosage adjustments. Although, in theory, warfarin dose increase ...